𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Fas and Fas ligand in human hepatocellular carcinoma

✍ Scribed by Tetsuo Takehara; Norio Hayashi

Publisher
Springer Japan
Year
2001
Tongue
English
Weight
38 KB
Volume
36
Category
Article
ISSN
0944-1174

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Fas and Fas ligand: strong co-expression
Fas and Fas ligand: strong co-expression in human hepatocytes surrounding hepatocellular carcinoma; can cancer induce suicide in peritumoural cells?
✍ Roskams, Tania; Libbrecht, Louis; Van Damme, Boudewijn; Desmet, Valeer πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 245 KB πŸ‘ 1 views

Fas (Apo-1, CD95), a member of the nerve growth factor/tumour necrosis factor receptor superfamily, mediates apoptosis in response to agonistic antibodies or Fas ligand (Fas-L) binding. Fas has been shown to be present on hepatocyte membranes in normal liver and in chronic hepatitis C. At the presen

Fas/Fas ligand system and apoptosis indu
Fas/Fas ligand system and apoptosis induction in testicular carcinoma
✍ Hans U. Schmelz; Michael Abend; Klaus Kraft; Ekkehard W. Hauck; Wolfgang Weidner πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 135 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Tumor‐infiltrating, Fas ligand (FasL)‐expressing lymphocytes are able to eliminate Fas‐bearing tumor cells by apoptosis induction. Activated cytotoxic T‐cells that express Fas may enter apoptosis in the presence of FasL tumor cells. To date, no studies of patients with te